Table 2.
Immediate management | Number achieved standard/total number of patients analysed | % of total | Number achieved standard/total number of patients evaluable† | % of number evaluable |
1. The patient’s conscious level should be documented using the Glasgow Coma Scale | 1283/1471 | 87% | 1283/1448 | 89% |
2. Blood cultures should be taken as soon as possible and within 1 hour of arrival at hospital | 326/1471‡ | 22% | 326/767§ | 42% |
3. LP should be performed within 1 hour of arrival at hospital provided that it is safe to do so | 8/1471¶ | 0.5% | 8/1379** | 0.6% |
4. Antibiotic treatment should be commenced within the first hour | 207/1471†† | 14% | 207/1083‡‡ | 19% |
5. Patients with meningitis and meningococcal sepsis should be cared for with the input of an infection specialist such as a microbiologist or a physician with training in infectious diseases and/or microbiology | 1148/1471§§ | 78% | 1148/1464 | 78% |
Investigations | ||||
6. Blood culture should be sent | 977/1471 | 66% | 977/1469 | 67% |
7. Blood pneumococcal PCR should be sent | 211/1471 | 14% | 211/1460 | 14% |
8. Blood meningococcal PCR should be sent | 232/1471 | 16% | 232/1461 | 16% |
9. CSF opening pressure should be documented | 655/1428¶¶ | 46% | 655/1361a | 48% |
10. CSF glucose with concurrent plasma glucose should be sent | 607/1428¶¶ | 43% | 607/1415 | 43% |
11. CSF protein should be sent | 1358/1428¶¶ | 95% | 1358/1420 | 96% |
12. Microscopy of the CSF should take place within 2 hours of the lumbar puncture | 596/1428¶¶ | 42% | 596/1203b | 50% |
13. CSF for pneumococcal PCR should be sent in all cases of suspected bacterial meningitis | 412/1428¶¶ | 29% | 412/1418 | 29% |
14. CSF for meningococcal PCR should be sent in all cases of suspected bacterial meningitis | 434/1428¶¶ | 30% | 434/1418 | 31% |
15. A swab of the posterior nasopharyngeal wall should be obtained as soon as possible, and sent for meningococcal culture, in all cases of suspected meningococcal meningitis/sepsis | 54/1471 | 4% | 54/1463c | 4% |
16. All patients with meningitis should have an HIV test | 646/1471 | 44% | 646/1459d | 44% |
Treatment | ||||
17. All patients with suspected meningitis or meningococcal sepsis should be given ceftriaxone or cefotaxime | 1039/1471e | 71% | 1039/1423f | 73% |
18. If the patient has, within the last 6 months, been to a country where penicillin resistant pneumococci are prevalent, intravenous vancomycin 15–20 mg/kg should be added 12-hourly (or 600 mg rifampicin 12-hourly intravenous or orally)g | See footnote | |||
19. Those aged 60 or over should receive 2 g intravenous ampicillin/amoxicillin 4-hourly in addition to a cephalosporin (1B) | 55/233 | 24% | 55/197h | 28% |
20. Immunocompromised patients (including diabetics and those with a history of alcohol misuse) should receive 2 g intravenous ampicillin/amoxicillin 4-hourly in addition to a cephalosporin | 26/115i | 23% | 26/99j | 26% |
21. If there is a clear history of anaphylaxis to penicillins or cephalosporins give intravenous chloramphenicol 25 mg/kg 6-hourly | 14/37 | 38% | 14/30k | 47% |
22. If Streptococcus pneumoniae is identified continue with intravenous benzylpenicillin 2.4 g 4-hourly, 2 g ceftriaxone intravenous 12-hourly or 2 g cefotaxime intravenous 6-hourly | 114/172 | 66% | 114/145l | 79% |
23. If number of meningitidis is identified 2 g ceftriaxone intravenous 12-hourly, 2 g cefotaxime intravenous 6-hourly or 2.4 benzylpenicillin intravenous 4-hourly may be given as an alternative | 52/76 | 68% | 52/68m | 76% |
24. If the patient is not treated with ceftriaxone (in meningococcal disease), a single dose of 500 mg ciprofloxacin orally should also be given | 0/2 | 0% | 0/2 | 0% |
25. If Listeria monocytogenes is identified Give 2 g ampicillin/amoxicillin intravenous 4-hourly and continue for at least 21 days. Cotrimoxazole 10–20 mg/kg or chloramphenicol are alternatives in cases of anaphylaxis to beta lactams | 4/7 | 57% | 4/6 | 67%n |
26. If Haemophilus influenzae is identified continue 2 g ceftriaxone intravenous 12-hourly or 2 g cefotaxime intravenous 6-hourly for 10 days | 9/14 | 64% | 9/13 | 69%o |
27. 10 mg dexamethasone intravenous 6-hourly should be started on admission, either shortly before or simultaneously with antibiotics | 67/1471 | 5% | 67/1435p | 5% |
28. If pneumococcal meningitis is confirmed dexamethasone should be continued for 4 days | 34/172q | 20% | 34/158r | 22% |
Critical care | ||||
29. The following patients should be transferred to critical care—those with a rapidly evolving rash, those with a GCS of 12 or less and those with uncontrolled seizures | 151/203s | 74% | 151/203 | 74% |
Notification | ||||
30. All cases of meningitis (regardless of aetiology) should be notified to the relevant public health authority | 236/1471 | 16% | 236/1465 | 16% |
*Only those audit standards that could be measured from the data collected.
†Excludes those where there were missing data and/or where not relevant.
‡Only 977 patients had blood cultures taken.
§Excluding those who did not have blood cultures taken and where data were missing.
¶1428 patients had an LP.
**Excludes those who did not have an LP and where data were not available.
††82 patients had data consistent with having antibiotics prior to admission, this might be due to confusion about whether admission meant admission to the emergency department or admission to a ward, or it may represent data entry error therefore, these figures are not included.
‡‡388 patients did not receive any antibiotics at all.
§§310 (21%) of patients were admitted under an infection specialist, all others received consulting advice only.
¶¶43 people did not have an LP.
aMissing data on 67.
b43 had no LP, 97 missing data, 128 time of microscopy was before or at the same time as the LP.
cPerformed in 15/76 (20%) of proven meningococcal cases.
d9 known HIV positive and 3 missing data.
e285 patients were not given any antibiotics at all.
f48 patients who were definitely given antibiotics had missing data on which antibiotics they were given.
gUsing mainland Europe data only and with reference to ECDC data—101 patients were documented to have travelled to a mainland European country within the previous 6 months. Travel history was not documented at all in 822 cases (56%). Of the 101 patients who had travelled to mainland Europe 54 (54%) had been to a country with a rate of penicillin resistant pneumococci of >5% (2017 data). 5/52 had no antibiotics. 0/47 had antibiotics to cover for penicillin resistant pneumococci.
h233 patients were aged over 60 but only 207 received antibiotics. Missing data for 10, 108 received amoxicillin at some point but only 55 received the correct dose.
iNot including those ≥60.
j15 did not received any antibiotics and missing data on 1.
k7 patients had no antibiotics at all.
l27 patients had insufficient antibiotic data.
m8 patient had insufficient antibiotic data.
n1 patient had insufficient antibiotic data.
oInsufficient antibiotic data on 1 person.
pMissing data on 36—11 on whether dexamethasone was received or not, 21 on the dose given and 4 on the timing.
qOnly 18 were given the correct dose (10 mg). Some received dexamethasone for longer than 4 days.
rMissing data on 14 individuals.
s7/11 patient with progressing rash, 131/176 patients with GCS <13 and 13/16 patients with uncontrolled seizures.
CSF, cerebrospinal fluid; GCS, Glasgow Coma Score; LP, lumbar puncture.